Publication | Closed Access
Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.
32
Citations
20
References
2010
Year
ERCC1 gene expression is inducible, contributes to oxaliplatin resistance, and is reversible by targeted suppression of ERCC1, identifying ERCC1 as a potential target for drug development.
| Year | Citations | |
|---|---|---|
Page 1
Page 1